|
1
|
Porporato PE, Dhup S, Dadhich RK, Copetti
T and Sonveaux P: Anticancer targets in the glycolytic metabolism
of tumors: A comprehensive review. Front Pharmacol. 2:492011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pelicano H, Martin DS, Xu RH and Huang P:
Glycolysis inhibition for anticancer treatment. Oncogene.
25:4633–4646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hamanaka RB and Chandel NS: Targeting
glucose metabolism for cancer therapy. J Exp Med. 209:211–215.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gatenby RA, Gawlinski ET, Gmitro AF,
Kaylor B and Gillies RJ: Acid-mediated tumor invasion: A
multidisciplinary study. Cancer Res. 66:5216–5223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Courtnay R, Ngo DC, Malik N, Ververis K,
Tortorella SM and Karagiannis TC: Cancer metabolism and the Warburg
effect: The role of HIF-1 and PI3K. Mol Biol Rep. 42:841–851. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poon E, Harris AL and Ashcroft M:
Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
Expert Rev Mol Med. 11:e262009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lew CR and Tolan DR: Targeting of several
glycolytic enzymes using rna interference reveals aldolase affects
cancer cell proliferation through a non-glycolytic mechanism. J
Biol Chem. 287:42554–42563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chan B, Manley J, Lee J and Singh SR: The
emerging roles of microRNAs in cancer metabolism. Cancer Lett.
356:301–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen J, Jiang Z, Wang B, Wang Y and Hu X:
Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2.
Cancer Lett. 316:204–210. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Xie J, Jiang Z, Wang B, Wang Y and
Hu X: Shikonin and its analogs inhibit cancer cell glycolysis by
targeting tumor pyruvate kinase-M2. Oncogene. 30:4297–4306. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Christofk HR, Vander Heiden MG, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vander Heiden MG, Christofk HR, Schuman E,
Subtelny AO, Sharfi H, Harlow EE, Xian J and Cantley LC:
Identification of small molecule inhibitors of pyruvate kinase M2.
Biochem Pharmacol. 79:1118–1124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rady P, Arany I, Bojan F and Kertai P:
Activities of four glycolytic enzymes (HK, PFK, PK and LDH) and
isozymic pattern of LDH in mouse lung tumor induced by urethan. J
Cancer Res Clin Oncol. 95:287–289. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boyland E, Goss GC and Williamsashman HG:
The hexokinase activity of animal tumours. Biochem J. 49:321–325.
1951. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gracy RW and Tilley BE: Phosphoglucose
isomerase of human erythrocytes and cardiac tissue. Methods
Enzymol. 41:392–400. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vora S, Halper JP and Knowles DM:
Alterations in the activity and isozymic profile of human
phosphofructokinase during malignant transformation in vivo and in
vitro: Transformation- and progression-linked discriminants of
malignancy. Cancer Res. 45:2993–3001. 1985.PubMed/NCBI
|
|
17
|
El-Bacha T, de Freitas MS and Sola-Penna
M: Cellular distribution of phosphofructokinase activity and
implications to metabolic regulation in human breast cancer. Mol
Genet Metab. 79:294–299. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pontremoli S, Melloni E, Salamino F,
Sparatore B, Michetti M and Horecker BL: Changes in activity of
fructose-1,6-bisphosphate aldolase in livers of fasted rabbits and
accumulation of crossreacting immune material. Proc Natl Acad Sci
USA. 76:6323–6325. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rieder SV and Rose IA: The mechanism of
the triosephosphate isomerase reaction. J Biol Chem. 234:1007–1010.
1959.PubMed/NCBI
|
|
20
|
Brenneman FN and Volk WA: Glyceraldehyde
phosphate dehydrogenase activity with triphosphopyridine nucleotide
and with diphosphopyridine nucleotide. J Biol Chem. 234:2443–2447.
1959.PubMed/NCBI
|
|
21
|
Yoshida A and Watanabe S: Human
phosphoglycerate kinase. I. Crystallization and characterization of
normal enzyme. J Biol Chem. 247:440–445. 1972.PubMed/NCBI
|
|
22
|
Rose ZB and Dube S: Phosphoglycerate
mutase. Kinetics and effects of salts on the mutase and
bisphosphoglycerate phosphatase activities of the enzyme from
chicken breast muscle. J Biol Chem. 253:8583–8592. 1978.PubMed/NCBI
|
|
23
|
Wold F and Ballou CE: Studies on the
enzyme enolase. II. Kinetic studies. J Biol Chem. 227:313–328.
1957.PubMed/NCBI
|
|
24
|
Christofk HR, Vander Heiden MG, Wu N,
Asara JM and Cantley LC: Pyruvate kinase M2 is a
phosphotyrosine-binding protein. Nature. 452:181–186. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mazurek S, Zwerschke W, Jansen-Durr P and
Eigenbrodt E: Metabolic cooperation between different oncogenes
during cell transformation: Interaction between activated ras and
HPV-16 E7. Oncogene. 20:6891–6898. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Patra KC and Hay N: The pentose phosphate
pathway and cancer. Trends Biochem Sci. 39:347–354. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roberts DJ and Miyamoto S: Hexokinase II
integrates energy metabolism and cellular protection: Akting on
mitochondria and TORCing to autophagy. Cell Death Differ.
22:248–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang D, Li J, Wang F, Hu J, Wang S and
Sun Y: 2-Deoxy-D-glucose targeting of glucose metabolism in cancer
cells as a potential therapy. Cancer Lett. 355:176–183. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu L, Xu J, Yuan W, Wu B, Wang H, Liu G,
Wang X, Du J and Cai S: The reversal effects of 3-bromopyruvate on
multidrug resistance in vitro and in vivo derived from human breast
MCF-7/ADR cells. PLoS One. 9:e1121322014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yanagawa T, Funasaka T, Tsutsumi S,
Watanabe H and Raz A: Novel roles of the autocrine motility
factor/phosphoglucose isomerase in tumor malignancy. Endocr Relat
Cancer. 11:749–759. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chiu CG, St-Pierre P, Nabi IR and Wiseman
SM: Autocrine motility factor receptor: A clinical review. Expert
Rev Anticancer Ther. 8:207–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ros S and Schulze A: Balancing glycolytic
flux: The role of 6-phosphofructo-2-kinase/fructose
2,6-bisphosphatases in cancer metabolism. Cancer Metab. 1:82013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Phan LM, Yeung SC and Lee MH: Cancer
metabolic reprogramming: Importance, main features and potentials
for precise targeted anti-cancer therapies. Cancer Biol Med.
11:1–19. 2014.PubMed/NCBI
|
|
34
|
Long F, Cai X, Luo W, Chen L and Li K:
Role of aldolase A in osteosarcoma progression and metastasis:
In vitro and in vivo evidence. Oncol Rep.
32:2031–2037. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun Y, Long JH and Zhou Y:
Angiopoietin-like 4 promotes melanoma cell invasion and survival
through aldolase A. Oncol Lett. 8:211–217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lincet H and Icard P: How do glycolytic
enzymes favour cancer cell proliferation by nonmetabolic functions?
Oncogene. 34:3751–3759. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kennedy KJ, Bressi JC and Gelb MH: A
disubstituted NAD+ analogue is a nanomolar inhibitor of
trypanosomal glyceraldehyde-3-phosphate dehydrogenase. Bioorg Med
Chem Lett. 11:95–98. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ahmad SS, Glatzle J, Bajaeifer K, Bühler
S, Lehmann T, Königsrainer I, Vollmer JP, Sipos B, Ahmad SS,
Northoff H, et al: Phosphoglycerate kinase 1 as a promoter of
metastasis in colon cancer. Int J Oncol. 43:586–590. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zieker D, Konigsrainer I, Tritschler I,
Löffler M, Beckert S, Traub F, Nieselt K, Bühler S, Weller M,
Gaedcke J, et al: Phosphoglycerate kinase 1 a promoting enzyme for
peritoneal dissemination in gastric cancer. Int J Cancer.
126:1513–1520. 2010.PubMed/NCBI
|
|
40
|
Wang J, Ying G, Wang J, Jung Y, Lu J, Zhu
J, Pienta KJ and Taichman RS: Characterization of phosphoglycerate
kinase-1 expression of stromal cells derived from tumor
microenvironment in prostate cancer progression. Cancer Res.
70:471–480. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ding H, Cheng YJ, Yan H, Zhang R, Zhao JB,
Qian CF, Zhang WB, Xiao H and Liu HY: Phosphoglycerate kinase 1
promotes radioresistance in U251 human glioma cells. Oncol Rep.
31:894–900. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hitosugi T, Zhou L, Elf S, Fan J, Kang HB,
Seo JH, Shan C, Dai Q, Zhang L, Xie J, et al: Phosphoglycerate
mutase 1 coordinates glycolysis and biosynthesis to promote tumor
growth. Cancer Cell. 22:585–600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Evans MJ, Saghatelian A, Sorensen EJ and
Cravatt BF: Target discovery in small-molecule cell-based screens
by in situ proteome reactivity profiling. Nat Biotechnol.
23:1303–1307. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Song Y, Luo Q, Long H, Hu Z, Que T, Zhang
X, Li Z, Wang G, Yi L, Liu Z, et al: Alpha-enolase as a potential
cancer prognostic marker promotes cell growth, migration and
invasion in glioma. Mol Cancer. 13:652014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Principe M, Ceruti P, Shih NY,
Chattaragada MS, Rolla S, Conti L, Bestagno M, Zentilin L, Yang SH,
Migliorini P, et al: Targeting of surface alpha-enolase inhibits
the invasiveness of pancreatic cancer cells. Oncotarget.
6:11098–11113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Jung DW, Kim WH, Park SH, Lee J, Kim J, Su
D, Ha HH, Chang YT and Williams DR: A unique small molecule
inhibitor of enolase clarifies its role in fundamental biological
processes. ACS Chem Biol. 8:1271–1282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Iqbal MA, Gupta V, Gopinath P, Mazurek S
and Bamezai RN: Pyruvate kinase M2 and cancer: An updated
assessment. FEBS Lett. 588:2685–2692. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mazurek S, Boschek CB, Hugo F and
Eigenbrodt E: Pyruvate kinase type M2 and its role in tumor growth
and spreading. Semin Cancer Biol. 15:300–308. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Miao P, Sheng S, Sun X, Liu J and Huang G:
Lactate dehydrogenase A in cancer: A promising target for diagnosis
and therapy. IUBMB Life. 65:904–910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Doherty JR and Cleveland JL: Targeting
lactate metabolism for cancer therapeutics. J Clin Invest.
123:3685–3692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lu CL, Qin L, Liu HC, Candas D, Fan M and
Li JJ: Tumor cells switch to mitochondrial oxidative
phosphorylation under radiation via mTOR-mediated hexokinase II
inhibition-a Warburg-reversing effect. PLoS One. 10:e01210462015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Spitz GA, Furtado CM, Sola-Penna M and
Zancan P: Acetylsalicylic acid and salicylic acid decrease tumor
cell viability and glucose metabolism modulating
6-phosphofructo-1-kinase structure and activity. Biochem Pharmacol.
77:46–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gomez LS, Zancan P, Marcondes MC,
Ramos-Santos L, Meyer-Fernandes JR, Sola-Penna M and Da Silva D:
Resveratrol decreases breast cancer cell viability and glucose
metabolism by inhibiting 6-phosphofructo-1-kinase. Biochimie.
95:1336–1343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhao YS, Zhu S, Li XW, Wang F, Hu FL, Li
DD, Zhang WC and Li X: Association between NSAIDs use and breast
cancer risk: A systematic review and meta-analysis. Breast Cancer
Res Treat. 117:141–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Blonski C, De Moissac D, Périé J and
Sygusch J: Inhibition of rabbit muscle aldolase by phosphorylated
aromatic compounds. Biochem J. 323:71–77. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Colell A, Green DR and Ricci JE: Novel
roles for GAPDH in cell death and carcinogenesis. Cell Death
Differ. 16:1573–1581. 2009. View Article : Google Scholar : PubMed/NCBI
|
